NanoScienceWorks

Biocure, Inc.

BioCure's technology originated from an extensive portfolio of advanced biomaterials and biosurface technologies licensed exclusively from CIBA Vision and its research partners – to exploit outside the ophthalmic field.

BioCure, Inc. is incorporated in Delaware and located in Norcross, Georgia, on the outskirts of Atlanta. We began operations in July 1999.

We are an established private, independent company, principally spun-off from the Novartis subsidiary, CIBA Vision.

The Center for Military Biomaterials Research (CeMBR), part of the New Jersey Center for Biomaterials at Rutgers University, has enabled the development of a breakthrough spray-on dressing for injuries. The trademarked GelSpray Liquid Bandage by BioCure Inc., a medical device company in Norcross, Ga., received clearance for marketing from the U.S. Food and Drug Administration (FDA) Feb. 1.

While created for the military, the GelSpray technology has potential uses in civilian health care. Future versions of the liquid bandage may be suitable for use by civilian rescue teams to treat traumatic wounds and burns, as well as in the treatment of diabetic ulcers, ostomies and post-op wounds. Future products based on the GelSpray technology platform will include active ingredients to treat infection and pain, and control severe bleeding.

Contact: Ruffin Booth, Secretary, 678-966-3408, rbooth@biocure.com

Related Content